Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma

Richard Turkington(Queen's University Belfast), Richard D. Kennedy(Queen's University Belfast), Tim Underwood(Southampton General Hospital), Jaine K. Blayney(Queen's University Belfast), Sophia R. Halliday(Queen's University Belfast), Christopher Steele(Almac (United Kingdom)), Juliane Perner(University of Cambridge), Manuel Salto‐Tellez(Queen's University Belfast), Éamon P McCarron(Salford Royal NHS Foundation Trust), Stephen McQuaid(Royal Victoria Eye and Ear Hospital), Rebecca C. Fitzgerald(University of Cambridge), Jacqueline A. James(Queen's University Belfast), Rosalie Douglas(Queen's University Belfast), Steven M. Walker(Almac (United Kingdom)), Andrena McCavigan(Almac (United Kingdom)), Fergus Noble(University Hospital Southampton NHS Foundation Trust), Eilis K Sutton(Queen's University Belfast), Ahmad Miremadi(Addenbrooke's Hospital), Gemma E. Logan(Almac (United Kingdom)), Shona MacRae(Hutchison/MRC Research Centre), Eileen E. Parkes(Nuffield Orthopaedic Centre), Laura A. Knight(Almac (United Kingdom)), Maria Secrier(University College London), D. Paul Harkin(Almac (United Kingdom)), Leanne Stevenson(Queen's University Belfast), Damian McManus(Belfast Health and Social Care Trust), Jan Bornschein(John Radcliffe Hospital), Martin Eatock(Queen's University Belfast), Robert O’Neill(UNSW Sydney)
Cited by 27


Related Papers